Skip to content
Screener

Pulse Biosciences, Inc. PLSE Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$24.66M-28.6%-$18.58M-10.6%-$17.43M+10.1%-$19.39M-52.9%-$19.17M-68.4%
$88K-12.0%$88K-24.8%$93K-23.1%$100K0.0%$100K0.0%
$4.97M-4.2%$1.91M-66.3%$4.97M-26.8%$5.62M+88.4%$5.19M+153%
-$18.71M-46.1%-$14.6M-7.9%-$14.76M-61.4%-$13.04M-44.5%-$12.81M-52.6%
$90K-12.6%$33K-26.7%$105K+98.1%$62K+63.2%$103K+255%
-$90K+26.8%-$33K+26.7%-$105K-98.1%-$62K-63.2%-$123K-324%
$52.1M$2.21M-85.1%$381K-99.2%$1.97M-96.8%$0
$33.3M+358%-$12.42M-1,100%-$14.48M-137%-$11.14M-121%-$12.93M-48.8%
-$18.8M-45.6%-$14.63M-7.8%-$14.86M-61.6%-$13.1M-44.6%-$12.91M-53.3%

FAQ

How much cash does Pulse Biosciences, Inc. generate?
Pulse Biosciences, Inc. (PLSE) generated -$61.1M in operating cash flow over the trailing twelve months.
What is Pulse Biosciences, Inc.'s free cash flow?
After $290.0K of capital expenditures, Pulse Biosciences, Inc.'s free cash flow was -$61.4M over the trailing twelve months, down 37.2% year over year.
Where does Pulse Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.